Reports filed under Pharmaceuticals, newest first.
The posts report on the medical practice of prescribing weight-loss medications to individuals suffering from anorexia. This is significant because it highlights a potential misuse of pharmaceutical treatments for eating disorders.
A study links Ozempic and Wegovy to a rare risk of sudden vision loss, raising concerns about the safety of these weight loss and diabetes medications. The posts highlight the potential long-term health impacts of these drugs.
The posts share a news report regarding a new regulation or procedure in Turkey. It states that patients with existing medical reports for medications can now obtain their prescriptions without visiting a doctor.
The thread discusses the return of the menopause drug Lenzetto to Spanish pharmacies in November, highlighting a development in healthcare accessibility and pharmaceutical availability. The posts emphasize the significance of this event for…
The thread discusses reports from pharmaceutical companies Eli Lilly and Novo Nordisk regarding GLP-1 weight-loss drugs. The reports suggest that these medications may have the potential to slow biological aging in patients.
The posts highlight a rare bipartisan consensus between Republicans and Democrats regarding the need to regulate pharmacy benefit managers (PBMs). It specifically notes that Tennessee and Arkansas have already initiated regulatory actions a…
The thread reports on the appointment of Tyler Reynolds as the new Director of Digital Medicine at GSK. This news highlights a leadership change in a global biopharma company's digital health division.
The thread discusses a new breakthrough in HIV prevention medication. It highlights the tension between the scientific success of the drug and the potential inequality regarding global access to the treatment.
The thread discusses a new breakthrough HIV prevention drug and raises concerns regarding its accessibility. It highlights the tension between scientific advancement and equitable distribution across different regions.
The posts discuss a new HIV prevention drug that is being hailed as a medical breakthrough. The core concern raised is the equitable distribution and accessibility of this medication.
The thread reports on a lawsuit filed by the Florida Attorney General against Pfizer and its CEO. The legal action centers on the company's claims regarding the safety of the COVID-19 vaccine.
The thread consists of repeated links to an article regarding actions against the Israeli pharmaceutical industry and human rights issues in the West Bank. It serves as a call to action or awareness regarding the intersection of corporate e…
The posts highlight a news report regarding the high demand for the weight-loss drug Wegovy. Doctors are warning that the surge in pre-orders may be driven by profit-seeking rather than medical necessity.
Multiple posts from Handelsblatt report on Novartis announcing a successful study result for a multiple sclerosis treatment. The posts are shared across different sections like Schlagzeilen, Wirtschaft, and Unternehmen, highlighting the sig…
The posts share an article regarding the pharmaceutical industry's commercialization of menopause treatments. It highlights how menopause is becoming a multi-billion dollar business opportunity for pharmaceutical companies.
The posts report that the pharmaceutical company Novartis has halted clinical trials for a cell therapy treatment. This decision follows reports of patient deaths during the study, highlighting safety concerns in advanced medical research.
Multiple posts from Handelsblatt report that AstraZeneca has received US approval for a new blood pressure medication. The posts are shared across different sections of the platform, highlighting the significance of the pharmaceutical compa…
The thread discusses the EU's agreement on a plan to address drug shortages, focusing on reducing dependence on China and India for pharmaceuticals. The posts highlight the Critical Medicines Act as a key part of this initiative, aiming to …
A study suggests that GLP-1 medications may not cause as much muscle shrinkage as previously believed, raising questions about their side effects and effectiveness. This could impact their use in weight management and related health treatme…
The thread discusses a study on public perception of Ozempic weight loss, highlighting the GLP-1 paradox and its implications for public health and pharmaceuticals.
The thread discusses a potential shift in the weight-loss drug market, suggesting that Ozempic may no longer be the dominant drug. The article highlights changes in the industry and the emergence of new players.
The thread discusses a study indicating no link between maternal use of acetaminophen (Tylenol) during pregnancy and increased autism risk in children, suggesting the drug's safety during pregnancy.
The thread discusses Rhythm Pharmaceuticals receiving approval from the European Commission for the drug IMCIVREE (setmelanotide) to treat obesity and control hunger in patients with acquired hypothalamic obesity. This marks a significant d…
The thread discusses Norgine's announcement of the European Commission's marketing authorization for XOLREMDI® (mavorixafor), the first treatment for WHIM syndrome in the EU. The posts highlight the approval process and the significance of …
The thread discusses a study linking GLP-1 drugs to cognitive impairment, suggesting the cause may not be what is commonly expected. This raises concerns about the safety and side effects of these medications, which are used for weight loss…
The thread discusses the issue of diclofenac, a pharmaceutical drug, contaminating waterways due to inadequate wastewater treatment, raising concerns about environmental and public health impacts.
The thread discusses the potential side effect of GLP-1 drugs like Ozempic and Wegovy on sexual desire, highlighting a concern not previously communicated to users. It raises awareness about the unexpected consequences of weight loss medica…
The thread discusses the unavailability of the weight-loss medication Wegovy in Quebec, highlighting the financial burden on patients and the perceived lack of medical benefits justifying the cost. The posts reference a news article from 98…
The thread discusses the refusal of Quebec to reimburse the Wegovy medication for weight loss due to excessive side effects, highlighting concerns about the drug's safety and healthcare costs. This issue is relevant as it reflects broader d…